In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Reliant licenses, then acquires Novartis's DynaCirc

Executive Summary

Reliant Pharmaceuticals (in-licenses branded drugs) acquired two-year exclusive US rights to use, promote, market, sell, and distribute Novartis Pharmaceuticals' DynaCirc (isradipine) family of products to treat hypertension. It paid $47.6mm for the license.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Contract
    • Product Purchase

Related Companies

Advertisement
UsernamePublicRestriction

Register